ASH evidence-based guidelines: is there a role for second allogeneic transplant after relapse?

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn , Issue , 2009, Pages 414-418

  Thakar, Monica S ^a   Forman, Stephen J ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; FLT3 PROTEIN, HUMAN; IMMUNOSUPPRESSIVE AGENT;

ACUTE DISEASE; ADULT; ALLOTRANSPLANTATION; DONOR; EVIDENCE BASED MEDICINE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MYELOID LEUKEMIA; PRACTICE GUIDELINE; RECURRENT DISEASE; REOPERATION; REVIEW;

ACUTE DISEASE; ADULT; EVIDENCE-BASED MEDICINE; FMS-LIKE TYROSINE KINASE 3; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOID; MALE; PRACTICE GUIDELINES AS TOPIC; RECURRENCE; REOPERATION; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 77949447691     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2009.1.414     Document Type: Review

References (17)